Solmeron, Adelai9da D.

HRN: 25-01-32  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/29/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/29/2025
09/04/2025
IV
600mg
Q8h
Infected Wound
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines